Main Article Content

Authors

In 2015, the journal Science chose CRISPR-Cas9 technology as the most important technological advance of science in the last years. This magazine announced the beginning of a new era of biotechnology in which it would be possible to edit, correct and modify the genetic information of any cell in a feasible, fast and cheap way; and most importantly, with high precision. Its implementation in research laboratories in basic and applied sciences could help to develop therapeutic strategies for the health area with the main objective of healing diseases with a known genetic origin, and that until now have been impossible to cure

Andres Castillo, Departamento de Biologia. Facultad de Ciencias Naturales y Exactas. Universidad del Valle. Cali, Colombia. Editor Asociado Revista Colombia Medica. Facultad de Salud, Universidad del Valle, Cali, Colombia

PhD en Ciencias Biomedicas Profesor Asistente. Departamento de Biologia. Facultad de Ciencias Naturales y Exactas. Universidad del Valle. Cali, Colombia.

Editor Asociado Revista Colombia Medica. Facultad de Salud, Universidad del Valle, Cali, Colombia
Castillo, A. (2024). Gene editing using CRISPR-Cas9 for the treatment of lung cancer. Colombia Medica, 47(4), 178–180. https://doi.org/10.25100/cm.v47i4.2856 (Original work published December 29, 2016)

Travis J. Breakthrough of the Year: CRISPR makes the cut. Science Magazine. 2015 http://www.sciencemag.org/news/2015/12/and-science-s-breakthrough-year

Cyranoski D. CRISPR gene-editing tested in a person for the first time. Nature. 2016;539:479–479.

Ishino Y, Shinagawa H, Makino K, Amemura M, Nakata A. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. Journal of Bacteriology. 1987;169(12):5429–5433.

Mojica FJ, Ferrer C, Juez G, Rodríguez-Valera F. Long stretches of short tandem repeats are present in the largest replicons of the Archaea Haloferax mediterranei and Haloferax volcanii and could be involved in replicon partitioning. Mol Microbiol. 1995;17(1):85–93.

Mojica FJ, Díez-Villaseñor C, Soria E, Juez G. Biological significance of a family of regularly spaced repeats in the genomes of Archaea, Bacteria and mitochondri. Mol Microbiol. 2000;36(1):244–246.

Mojica FJ, Díez-Villaseñor C, García-Martínez J, Soria E. Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol. 2005;60(2):174–1826.

Horvath P, Barrangou R. CRISPR/Cas, the Immune System of Bacteria and Archaea. Science. 2010;327:167–170. [PubMed]

Marraffini LA, Sontheimer EJ. CRISPR interference RNA-directed adaptive immunity in bacteria and archaea. Nat Rev Genet. 2010;11(3):181–190.

Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337(6096):816–821.

Gebler C, Lohoff M, Paszkowski-Rogacz M, Mircetic J, Chakraborty D, Camgoz A, Hamann MV. Inactivation of Cancer Mutations Utilizing CRISPR/Cas9. J Natl Cancer Inst. 2016;109(1):djw183–djw183.

Cyranosky D. Chinese scientists to pioneer first human CRISPR trial. Nature. 2016;535:476–477. [PubMed]

National Academies of Sciences Engineering and Medicine . International Summit on Human Gene Editing: A Global Discussion. Washington, DC: The National Academies Press; 2016.

Hirsch F, Lévy Y, Chneiweiss H. CRISPR-Cas9 A European position on genome editing. Nature. 2017;541(7635):30.

Downloads

Download data is not yet available.
Received 2017-01-13
Accepted 2017-01-17
Published 2024-06-11